Literatur
- 1
Bax L. et al .
Stent Replacement in Patients with Atherosclerotic
Renal Artery Stenosis and Impaired Renal Function.
Ann
Intern Med.
2009;
150
840-848
- 2
Hansson L. et al .
Effects of intensive blood-pressure lowering
and low-dose aspirin in patients with hypertension: principal results
of the Hypertension Optimal treatment (HOT) randomised trial.
Lancet.
1998;
351
1755
- 3
Li N C, Lee A, Whitmer R A. et al .
Use of angiotensin receptor blockers and
risk of dementia in a predominantly male population: prospective
cohort analysis.
BMJ.
2010;
340
b5409
- 4
Mancia G, Laurent S, Agabiti-Rosei E. et al .
Reappraisal of the European Hypertension Guidelines.
J Hypertens.
2009;
27
2121-2158
- 5
Middeke M.
Hypertensiologie 2008.
Dtsch Med Wochenschr.
2008;
133
1344-1347
- 6
Middeke M.
Hypertensiologie 2009.
Dtsch Med Wochenschr.
2009;
134
1312-1315
- 7
Ruilope L M, Dukat A, Böhm M. et al .
Blood-pressure reduction with LCZ696, a
novel dual-acting inhibitor of the angiotensin II receptor and neprilysin:
a randomised, double-blind, placebo-controlled, active comparator
study.
Lancet.
2010;
375
1255-1266
- 8
Sink K M, Leng X, Williamson J. et al .
Angiotensin-Converting Enzyme Inhibitors
and Cognitive Decline in Older Adults With Hypertension.
Arch
Intern Med.
2009;
169
1195-1202
- 9
The ACCORD Study Group .
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes
Mellitus.
N Engl J Med.
2010;
362
1575-1585
- 10
The ASTRAL Investigators .
Revascularization versus Medical-Therapy for Renal-Artery Stenosis.
N Engl J Med.
2009;
361
1953-1962
- 11
Weber M A, Black H, Bakris G. et al .
A selective endothelin-receptor antagonist
to reduce blood pressure in patients with treatment-resistent hypertension:
a randomised, double-blind, placebo-controlled trial.
Lancet.
2009;
374
1423-1431
Prof. Dr. Martin Middeke
Hypertoniezentrum München
Dienerstr.
12
80331 München
URL: http://www.hypertoniezentrum.de
